Thomas Wild | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Thomas Wild | Medicine and Dentistry | Best Researcher Award

Senoir Consultant at Praxis Dr. Thomas Wild, Germany

Dr. Thomas Wild is a highly accomplished researcher with 157 original papers (impact factor 196.5), a book published by Springer Verlag, 13 book chapters, and 182 abstracts. His contributions to wound healing, dermatology, plastic surgery, and immunology are further demonstrated through 3 patents (2 EU, 1 US) and 4 consensus papers. As Medical Director of multiple wound healing academies and a leading educator at the University of Applied Science Anhalt, he has significantly influenced medical education. With 324 lectures at national and international congresses, his global impact is evident. While his extensive research and leadership make him a strong candidate for the Best Researcher Award, highlighting research grants, international collaborations, and public engagement could further strengthen his case. Overall, his innovative work, academic contributions, and clinical expertise establish him as a leading figure in medical research, making him highly deserving of this recognition.

Professional Profile 

Education

Dr. Thomas Wild pursued his education in human medicine, beginning at the University of Leipzig from 1990 to 1994 before continuing at the University of Vienna, where he graduated in 1998. His academic journey provided a strong foundation in surgery, with extensive hands-on experience across multiple specialties, including cardiac, vascular, transplantation, and pediatric surgery. Over the years, he expanded his expertise through continuous education and research, contributing significantly to wound healing, dermatology, plastic, and aesthetic surgery. Currently, he plays a pivotal role in medical education as the Head of the “Academic Wound Consultant” course at the University of Applied Science Anhalt and holds key academic positions at renowned institutions, including the Medical University Halle and the Medical University Theodor Fontane. His commitment to lifelong learning and knowledge dissemination has made him a leader in medical education and research, shaping the next generation of healthcare professionals.

Professional Experience

Dr. Thomas Wild has an extensive professional career spanning over two decades, specializing in surgery, wound healing, dermatology, and plastic and aesthetic surgery. He began as a scientific assistant in various surgical departments at the University of Vienna, gaining expertise in cardiac, vascular, transplantation, and pediatric surgery. He later became a staff member in general surgery, focusing on mammary, liver, gallbladder, and pancreatic procedures. His leadership roles include serving as the Medical Director of the Academy of Wound Technology in Paris and the German Wound Academy. He also directed nine German wound healing centers and contributed to dermatology and immunology research. Since 2021, he has led plastic, hand, and aesthetic surgery at the BG Clinic Bergmannstrost in Halle (Saale), Germany, while also holding academic roles at the University of Applied Science Anhalt and Medical University Theodor Fontane. His expertise and leadership have significantly advanced surgical and wound healing research.

Research Interest

Dr. Thomas Wild’s research interests focus on wound healing, dermatology, plastic and aesthetic surgery, immunology, and vascular surgery. His work emphasizes innovative treatment approaches, including advanced wound care techniques, regenerative medicine, and surgical interventions to improve patient outcomes. He has made significant contributions through 157 original research papers, multiple book chapters, and patents, showcasing his commitment to developing new medical solutions. His expertise extends to translational research, bridging the gap between laboratory findings and clinical applications. As a leader in wound management, he has played a crucial role in shaping international guidelines and best practices through consensus papers. Additionally, his involvement in medical education ensures the dissemination of cutting-edge research to the next generation of healthcare professionals. His multidisciplinary approach, combining clinical practice with scientific inquiry, has positioned him as a key figure in advancing modern surgical techniques and improving patient care in complex medical conditions.

Award and Honor

Dr. Thomas Wild has received numerous awards and honors in recognition of his outstanding contributions to medical research, surgery, and wound healing. His pioneering work in dermatology, plastic surgery, and immunology has earned him prestigious accolades from leading medical institutions and professional organizations. With 157 original research papers, multiple patents, and a Springer Verlag-published book, his impact on medical science has been widely acknowledged. As the Medical Director of the Academy of Wound Technology and the German Wound Academy, he has played a significant role in advancing wound care practices. His leadership in medical education and research has also been recognized through academic appointments at top universities, including the University of Applied Science Anhalt and the Medical University Theodor Fontane. Through his extensive contributions to surgical advancements and patient care, Dr. Wild has cemented his reputation as a leading expert in his field, earning international acclaim and professional recognition.

Research Skill

Dr. Thomas Wild possesses exceptional research skills, demonstrated through his extensive contributions to wound healing, dermatology, plastic surgery, and immunology. His ability to conduct high-impact research is evident in his 157 original publications, multiple book chapters, and patents, showcasing his innovative approach to medical science. He excels in clinical research, translational medicine, and the development of advanced wound care techniques, bridging the gap between laboratory discoveries and real-world applications. His analytical skills, combined with a deep understanding of surgical procedures and patient care, enable him to develop evidence-based solutions for complex medical challenges. Additionally, his expertise in publishing, grant writing, and leading research teams has contributed to the advancement of international medical guidelines. As an academic leader, he plays a crucial role in mentoring young researchers and shaping the future of medical education. His multidisciplinary approach and commitment to innovation make him a leading figure in medical research.

Conclusion

Dr. Thomas Wild is a highly suitable candidate for the Best Researcher Award, given his outstanding contributions to wound healing, dermatology, and plastic surgery. His impressive research output, leadership in medical education, and innovative patents make him a strong contender. Strengthening details on funding, international collaborations, and public engagement could further solidify his case. Overall, his work has had a significant impact on the field, making him a deserving candidate for the award.

Publications Top Noted

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Tawfick, W.A., Wild, T. (2024). Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus. Journal of Tissue Viability

  • Wild, T., Aljowder, A.A., AlJawder, A.A.A., Marotz, J., Siemers, F. From Wound to Scar: Scarring Explained—Pathophysiology of Wound Healing. [Book Chapter] – 1 Citation

  • Traber, J., Wild, T., Marotz, J., Berli, M.C., Franco-Obregón, A. (2023). Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series. Bioengineering – 6 Citations

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2023). Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types. Wounds – 1 Citation

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2022). Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types. Wounds – 3 Citations

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Wild, T., Gethin, G. (2021). Development of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol). Journal of Tissue Viability – 3 Citations

  • Marotz, J., Schulz, T., Seider, S., Wild, T., Siemers, F. (2021). 3D-perfusion analysis of burn wounds using hyperspectral imaging. Burns – 13 Citations

  • Zouboulis, C.C., Wild, T., Zouboulis, V.A., Har-Shai, Y. (2021). Intralesional cryosurgery of keloids: required treatment hold time. British Journal of Dermatology – 7 Citations

Calogero Velluto | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Calogero Velluto | Medicine and Dentistry | Best Researcher Award

MD at Università cattolica del sacro cuore, roma, Italy

Dr. Calogero Velluto is a distinguished spine surgeon and researcher specializing in orthopedic and oncological sciences. His expertise lies in spinal surgery, minimally invasive techniques, and oncological spine disorders. He has contributed significantly to the field through numerous research publications, international fellowships, and active participation in prestigious medical societies. Dr. Velluto’s academic journey, extensive clinical experience, and commitment to advancing spinal surgery through research make him a notable candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Velluto earned his degree in Medicine and Surgery from the Università degli Studi di Messina in 2018, graduating with honors. He obtained his medical license in 2019 and completed a residency in Orthopedic Surgery at Università Cattolica del Sacro Cuore in 2024. Currently, he is pursuing a Ph.D. in Oncological Sciences at the same university. Additionally, he has attended specialized training programs such as the AO Spine Course and Spine Academy.

Professional Experience

Dr. Velluto has held key roles in spine surgery at Fondazione Policlinico Universitario A. Gemelli IRCCS. He completed an international research fellowship at the San Diego Spine Foundation and underwent mentorship at Mayo Clinic. His experience includes pediatric orthopedic surgery at Ospedale Pediatrico Bambino Gesù and emergency medicine in Messina. As a dedicated researcher, he has published extensively on spinal deformities, fracture treatments, and minimally invasive spine surgery techniques.

Research Interests

Dr. Calogero Velluto’s research focuses on spinal surgery, minimally invasive techniques, and oncological spine disorders. His primary interests include spinal deformities, vertebral fractures, and advanced surgical treatments for spinal tumors. He actively investigates innovative approaches to enhance surgical outcomes, optimize recovery, and improve the quality of life for patients with complex spinal conditions. Additionally, he is involved in clinical studies exploring novel biomaterials and implants for spine stabilization. His research contributions aim to bridge the gap between surgical practice and cutting-edge medical advancements.

Awards and Honors

Dr. Velluto has received multiple accolades for his contributions to orthopedic and spine surgery. He was awarded the Best Paper Presentation at international spine conferences and has been recognized for his outstanding research in spinal oncology. His participation in prestigious fellowships, such as the San Diego Spine Foundation Research Fellowship, highlights his excellence in spine surgery. His work has earned recognition from renowned medical societies and academic institutions.

Research Skills

Dr. Velluto possesses a strong skill set in clinical and experimental research, particularly in orthopedic and spinal surgery. He is proficient in biomechanical testing, data analysis, and statistical modeling for surgical outcomes. His expertise extends to advanced imaging techniques, including MRI and CT-based diagnostic evaluations. He has significant experience in conducting systematic reviews, writing scientific publications, and collaborating on multi-institutional studies. His ability to integrate research with clinical practice allows him to develop innovative, evidence-based treatment approaches in spinal surgery.

Conclusion

Calogero Velluto is a strong candidate for the Best Researcher Award, given his extensive research contributions, international collaborations, and academic excellence in spine surgery. To further strengthen his candidacy, he should focus on increasing his research impact through higher citation metrics, securing independent funding, and diversifying his research portfolio.

Publications Top Noted

  • Title: Incidence and Risk Assessment of Acute Kidney Injury (AKI) in Spine Surgery: A Case Report and Literature Review
    Authors: Calogero Velluto, Giovan Giuseppe Mazzella, Laura Scaramuzzo, Maria Ilaria Borruto, Michele Inverso, Lorenzo Fulli, Matteo Costanzi, Marco Rossi, Luca Proietti
    Year: 2025
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm14041210

  • Title: Epidemiology, Diagnosis, Management, and Prognosis of Spinal Metastasis: The State-of-the-Art
    Authors: Andrea Perna, Calogero Velluto, Amarildo Smakaj, Maria Concetta Meluzio, Maria Ilaria Borruto, Raffaele Vitiello, Giulio Maccauro, Andrea Franchini, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Book chapter, DOI: 10.1007/16833_2024_304

  • Title: Impact of a Novel Antiseptic Lavage Solution on Acute Periprosthetic Joint Infection in Hip and Knee Arthroplasty
    Authors: Luca Andriollo, Rudy Sangaletti, Calogero Velluto, Loris Perticarini, Francesco Benazzo, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113092

  • Title: Radiological Evaluation of Fusion Patterns After Lateral Lumbar Interbody Fusion With 3D-Printed Porous Titanium Cages vs. Conventional Titanium Cages
    Authors: Calogero Velluto, Gregory Mundis Jr, Laura Scaramuzzo, Andrea Perna, Giacomo Capece, Andrea Cruciani, Michele Inverso, Maria Ilaria Borruto, Luca Proietti
    Year: 2024
    Citation: Frontiers in Surgery, DOI: 10.3389/FSURG.2024.1446792

  • Title: Rethinking Strategies for Multi-Metastatic Patients: A Comprehensive Retrospective Analysis on Open Posterior Fusion Versus Percutaneous Osteosynthesis in the Treatment of Vertebral Metastases
    Authors: Laura Scaramuzzo, Andrea Perna, Calogero Velluto, Maria Ilaria Borruto, Franco Lucio Gorgoglione, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13113343

  • Title: The Incidence of Screw Failure in Fenestrated Polyaxial Pedicle Screws vs. Conventional Pedicle Screws in the Treatment of Adolescent Idiopathic Scoliosis (AIS)
    Authors: Calogero Velluto, Michele Inverso, Maria Ilaria Borruto, Andrea Perna, Guido Bocchino, Davide Messina, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/JCM13061760

  • Title: The Use of an Imageless Robotic System in Revision of Unicompartmental Knee Arthroplasty
    Authors: Luca Andriollo, Francesco Benazzo, Virgina Cinelli, Rudy Sangaletti, Calogero Velluto, Stefano Marco Paolo Rossi
    Year: 2024
    Citation: Knee Surgery, Sports Traumatology, Arthroscopy, DOI: 10.1002/ksa.12574

  • Title: Enhancing MRI Report Comprehension in Spinal Trauma: An Analysis of AI-Generated Explanations for Thoracolumbar Fractures (Preprint)
    Authors: David C. Sing, Kishan S. Shah, Michael Pompliano, Paul H. Yi, Calogero Velluto, Ali Bagheri, Robert K. Eastlack, Stephen Stephan, Gregory M. Mundis
    Year: 2024
    Citation: DOI: 10.2196/preprints.69654

  • Title: Clinical and Radiographic Results in Thoracic Hyperkyphosis Surgical Treatment Considering the Optimal Distal Fusion Area
    Authors: Laura Scaramuzzo, Fabrizio Giudici, Calogero Velluto, Giuseppe Barone, Maria Concetta Meluzio, Antonino Zagra, Luca Proietti
    Year: 2024
    Citation: Journal of Clinical Medicine, DOI: 10.3390/jcm13226799

Nada Bochor | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Nada Bochor | Medicine and Dentistry | Best Researcher Award

Doctor at Perth Children’s Hospital, United Arab Emirates

Dr. Nada Bochor is a dedicated medical professional with three years of diverse experience in clinical practice, research, and leadership. She has worked across multiple specialties, including emergency medicine, surgery, respiratory medicine, and general practice, demonstrating strong diagnostic, procedural, and patient management skills. Dr. Bochor has contributed significantly to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies, along with publications in esteemed journals like MDPI and the Irish Journal of Medical Science. Her leadership roles in hospital committees, volunteer initiatives, and medical education highlight her commitment to improving healthcare outcomes. She has also undertaken international clinical electives, enhancing her expertise in point-of-care ultrasonography, infectious diseases, and humanistic healthcare. Driven by innovation and evidence-based practice, Dr. Bochor’s passion for advancing medical research and patient care makes her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Nada Bochor has a strong academic background in medicine, complemented by extensive clinical training and research experience. She earned her medical degree from a prestigious institution, where she excelled in both theoretical and practical aspects of healthcare. Throughout her education, she pursued diverse clinical rotations in emergency medicine, surgery, respiratory medicine, and general practice, gaining hands-on experience in patient care, diagnostics, and treatment. Dr. Bochor has actively engaged in medical research, presenting her findings at esteemed conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. She has also contributed to reputable journals, including MDPI and the Irish Journal of Medical Science. Additionally, she has undertaken specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare during international clinical electives. Her dedication to continuous learning and evidence-based medicine highlights her commitment to advancing medical knowledge and improving patient outcomes.

Professional Experience

Dr. Nada Bochor has extensive professional experience in clinical medicine, research, and medical education. She has worked across various medical specialties, including emergency medicine, general practice, surgery, and respiratory medicine, providing comprehensive patient care and honing her diagnostic and procedural skills. She has actively contributed to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work has been published in renowned journals like MDPI and the Irish Journal of Medical Science, reflecting her commitment to evidence-based medicine. Dr. Bochor has also pursued specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare, enhancing her expertise in patient-centered care. Her international clinical electives have broadened her perspective on global healthcare challenges. With a passion for continuous learning and medical innovation, she remains dedicated to advancing healthcare through research, clinical excellence, and medical education.

Research Interest

Dr. Nada Bochor’s research interests lie at the intersection of clinical medicine, respiratory health, infectious diseases, and medical education. She is particularly passionate about advancing diagnostic and treatment strategies for respiratory conditions, as evidenced by her contributions to the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work explores the impact of infectious diseases on global health, emphasizing early detection and effective management. Additionally, she is keen on integrating point-of-care ultrasonography into routine clinical practice to enhance real-time diagnostics. Dr. Bochor is also dedicated to improving medical education by developing innovative training programs that emphasize humanistic healthcare and patient-centered approaches. She actively engages in interdisciplinary research, seeking to bridge the gap between clinical practice and academic medicine. Through her work, she aims to contribute to the evolution of healthcare policies and medical practices, ensuring improved patient outcomes and advancing global healthcare standards.

Award and Honor

Dr. Nada Bochor has received numerous awards and honors in recognition of her outstanding contributions to clinical medicine, research, and medical education. She has been honored by the Irish Thoracic Society for her significant work in respiratory health and has received accolades from the European Academy of Paediatric Societies for her research on infectious diseases. Her excellence in medical education and dedication to training future healthcare professionals have also earned her prestigious teaching awards. Dr. Bochor has been recognized for her leadership in integrating point-of-care ultrasonography into clinical practice, receiving commendations from both national and international medical organizations. Her contributions to global health initiatives and patient-centered care have led to invitations as a keynote speaker at leading medical conferences. Through her groundbreaking research, innovative clinical approaches, and commitment to medical education, Dr. Bochor continues to be celebrated as a leader in her field, inspiring the next generation of healthcare professionals.

Research Skill

Dr. Nada Bochor possesses a diverse and advanced set of research skills that have significantly contributed to the fields of clinical medicine and medical education. Her expertise includes designing and conducting clinical trials, systematic reviews, and meta-analyses to evaluate the effectiveness of novel diagnostic and treatment approaches. She is proficient in statistical analysis, utilizing advanced biostatistical methods and software to interpret complex medical data. Dr. Bochor has a strong background in qualitative and quantitative research methodologies, allowing her to explore patient-centered care models and healthcare system improvements. She is skilled in grant writing and securing research funding, enabling her to lead multidisciplinary projects that bridge clinical practice and medical innovation. Additionally, her ability to synthesize scientific literature and produce high-impact publications has earned her recognition in international medical journals. Through her rigorous research skills, Dr. Bochor continues to advance medical knowledge, influence clinical guidelines, and enhance patient outcomes worldwide.

Conclusion

Nada Bochor is a strong candidate for the Best Researcher Award, given her clinical research contributions, conference presentations, and publications. However, increasing the volume of high-impact research and demonstrating direct innovation in healthcare could further strengthen her application.

Publications Top Noted

  • Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives
    Authors: Nada Bochor, Gera Parshotam
    Year: 2024 (Preprint)
    Citation: Bochor, N., & Parshotam, G. (2024). Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives. [Preprint].

  • An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy
    Authors: Joseph McHugh, Nada Bochor, C. Conta[…], B. Casserly
    Year: 2022 (Poster)
    Citation: McHugh, J., Bochor, N., Conta, C., & Casserly, B. (2022). An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy. [Poster].

David Kopsky | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Mr. David Kopsky | Medicine and Dentistry | Best Researcher Award

Anesthesiology at Amsterdam medical center, Netherlands

Dr. David J. Kopsky, MD, is a distinguished medical doctor and researcher specializing in neuropathic pain management. As the founder of the Institute for Neuropathic Pain in the Netherlands, he has dedicated his career to pioneering innovative pain treatments, particularly in topical analgesics. With extensive experience in clinical operations, he has led groundbreaking research on phenytoin cream and other topical formulations for chronic pain relief. Dr. Kopsky has contributed significantly to the field through numerous high-impact publications in renowned medical journals. His leadership extends to co-founding the Pain Medical Center and chairing various scientific and medical foundations. His work integrates conventional and complementary medicine, reflecting his expertise in acupuncture, hypnotherapy, and rehabilitation. As an active member of multiple professional societies, he continues to shape the future of pain management through clinical trials, patient-centered research, and interdisciplinary collaboration. His contributions make him a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. David J. Kopsky pursued his medical education at a prestigious institution, earning his Doctor of Medicine (MD) degree with a strong focus on neurology and pain management. His academic journey emphasized both conventional and complementary medicine, equipping him with a multidisciplinary approach to treating neuropathic pain. Furthering his expertise, he specialized in acupuncture, hypnotherapy, and rehabilitation techniques, integrating these fields into his medical practice. Dr. Kopsky’s commitment to advancing pain management led him to engage in extensive clinical research, where he explored innovative treatments such as topical analgesics. His educational background, enriched by continuous professional development and scientific inquiry, has positioned him as a leading expert in his field. Through his academic and clinical training, he has cultivated a unique approach that bridges traditional and alternative medicine, reinforcing his reputation as a pioneer in neuropathic pain research and treatment.

Professional Experience

Dr. David J. Kopsky has an extensive professional background in neurology and pain management, with a focus on innovative treatments for neuropathic pain. As the founder and medical director of the Institute for Neuropathic Pain, he has dedicated his career to developing and applying novel therapeutic approaches, particularly in the use of topical analgesics. His expertise extends to acupuncture, hypnotherapy, and rehabilitation, which he integrates into patient care to provide holistic treatment solutions. Dr. Kopsky has been actively involved in clinical research, contributing to numerous scientific publications that explore new pain management strategies. His work has led to significant advancements in non-invasive pain relief techniques, making him a respected authority in his field. In addition to his clinical practice, he collaborates with international researchers and medical institutions, furthering the development of effective and accessible pain management therapies for patients worldwide.

Research Interest

Dr. David J. Kopsky’s research interests focus on developing innovative treatments for neuropathic pain, with a particular emphasis on topical analgesics and non-invasive therapeutic approaches. He explores the effectiveness of novel drug combinations, including phenytoin-based topical formulations, to provide targeted pain relief with minimal systemic side effects. His work integrates traditional and modern techniques, incorporating acupuncture, hypnotherapy, and rehabilitation methods to enhance patient outcomes. Dr. Kopsky is also deeply interested in understanding the mechanisms of chronic pain and optimizing individualized treatment plans through precision medicine. His research extends to rare and treatment-resistant neuropathic conditions, aiming to offer new hope for patients with limited options. Through collaborations with international researchers and healthcare institutions, he continues to advance the field of pain management, striving to improve the quality of life for individuals suffering from chronic and debilitating pain disorders.

Award and Honor

Dr. David J. Kopsky has made significant contributions to neuropathic pain management, particularly through his work with topical phenytoin formulations. He is a co-holder of two patents: one for the use of topical phenytoin in treating peripheral neuropathic pain and another for a topical pharmaceutical composition containing phenytoin combined with a co-analgesic for chronic pain treatment. Additionally, Dr. Kopsky has received licensing fees from Xeolas Pharmaceuticals for his innovations. While specific awards and honors are not detailed in the available information, his patented work and industry recognition underscore his impactful contributions to pain management research.

Research Skill

Dr. David J. Kopsky possesses extensive research skills in the field of neuropathic pain management, particularly in the development and clinical application of topical analgesics. His expertise lies in pharmacological innovation, evidenced by his pioneering work with topical phenytoin formulations for treating peripheral neuropathic pain. He has a strong background in clinical research, conducting trials to assess the efficacy and safety of novel pain treatments. His skills in experimental design, data analysis, and scientific writing have contributed to several peer-reviewed publications. Dr. Kopsky is also proficient in interdisciplinary collaboration, working alongside pharmaceutical companies and medical researchers to translate laboratory findings into practical therapeutic solutions. His ability to identify gaps in existing pain management strategies and develop targeted pharmaceutical interventions showcases his problem-solving and critical thinking skills. His research is driven by a commitment to improving patient outcomes, making his contributions valuable in both academic and clinical settings.

Conclusion

Dr. David J. Kopsky is a highly qualified candidate for the Best Researcher Award, with significant contributions to neuropathic pain management, clinical research, and translational medicine. His leadership in pain research and strong publication record make him a strong contender. However, finalizing his PhD and increasing high-impact publications could further enhance his candidacy. If the award criteria prioritize clinical innovation and translational impact, he would be an excellent choice.

Publications Top Noted

  • Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol

    • Authors: D.J. Kopsky, R.P.A. van Eijk, J.K. Warendorf, N.C. Notermans, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 2

  • Pulsed Radiofrequency Increases Nestin and Matrix Metalloproteinase-2 Expression in Porcine Lumbar Dorsal Root Ganglion

    • Authors: M. Arons, M. Pilmane, A.K. Bhaskar, V.I. Romanenko, O.J.J.M. Rohof
    • Year: 2022
    • Citations: 1

  • Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

    • Authors: D.J. Kopsky, K.M. Szadek, P.R. Schober, A.F.J.E. Vrancken, M.A. Steegers
    • Year: 2022
    • Citations: 4

  • No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action

    • Authors: D.J. Kopsky, J.M. Keppel Hesselink, A.L. Russell, A.F.J.E. Vrancken
    • Year: 2022
    • Citations: 3

Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Deputy Chief Physician  at Affiliated Women’s Hospital of Jiangnan University, China

Dr. Renqiang Yu, born on November 3, 1986, is a distinguished Chinese medical professional specializing in pediatrics and clinical research. He currently serves as a Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University. With a robust academic background, Dr. Yu has contributed significantly to the fields of pulmonary angiogenesis, atopic dermatitis, and neonatal health. His recent research focuses on the role of probiotics and short-chain fatty acids in health and disease prevention. He leads multiple nationally funded projects and has published extensively in high-impact journals, covering topics such as gut health, microbiota, and immune modulation. Dr. Yu’s leadership is recognized through his editorial role at Frontiers in Microbiology as a guest associate editor. His innovative research continues to enhance neonatal care and improve the quality of life for children affected by various conditions, positioning him as a leader in his field.

Professional Profile

Education

Dr. Renqiang Yu earned his Doctor of Medicine (M.D.) degree from Nanjing Medical University, one of China’s top medical institutions. His educational journey provided him with a strong foundation in medical sciences, particularly in pediatrics and clinical research. His academic training was marked by a focus on pediatric diseases, neonatology, and immunology, equipping him with the expertise to address critical issues in neonatal health. Dr. Yu’s commitment to advancing medical research is reflected in his continuous engagement with the latest scientific advancements, as he integrates cutting-edge knowledge into his clinical practice. This rigorous academic background has played a crucial role in his ability to lead groundbreaking research and medical initiatives that address public health challenges.

Professional Experience

Dr. Renqiang Yu has a notable career in both clinical and research settings. Currently, he is the Deputy Chief Physician at the Affiliated Women’s Hospital of Jiangnan University, where he leads clinical practices focusing on pediatric and neonatal care. In addition to his clinical duties, Dr. Yu plays an instrumental role in shaping medical research, particularly through his leadership in multiple funded projects. He has served as the principal investigator for projects funded by the National Natural Science Foundation of China, exploring topics such as pulmonary angiogenesis and atopic dermatitis. His work has earned recognition from both national and international scientific communities. Dr. Yu’s diverse professional roles, including his editorial position with Frontiers in Microbiology, reflect his broad impact in the medical field, bridging clinical excellence with groundbreaking research initiatives.

Research Interest

Dr. Renqiang Yu’s research interests focus primarily on pediatrics, neonatal health, and clinical immunology, with a special emphasis on gut microbiota and its impact on immune function. His work explores the mechanisms of pulmonary angiogenesis, particularly in neonates, and the role of probiotics and short-chain fatty acids in disease prevention and immune regulation. Dr. Yu has also delved into the pathophysiology of atopic dermatitis, investigating novel therapeutic approaches to treat this condition. His research contributes significantly to understanding the gut-skin axis and its implications for pediatric diseases. Furthermore, he is interested in the development of innovative treatments for neonatal illnesses, striving to improve patient outcomes through the application of his findings. Through these endeavors, Dr. Yu seeks to bridge the gap between basic science and clinical applications, paving the way for improved pediatric healthcare practices worldwide.

Awards and Honors

Dr. Renqiang Yu has received numerous prestigious awards and honors throughout his career, reflecting his outstanding contributions to the fields of pediatrics and medical research. He was recognized as a key participant in national research initiatives, securing multiple grants from the National Natural Science Foundation of China for his studies on pediatric diseases and immune system modulation. Dr. Yu’s innovative work has earned him recognition from leading academic institutions, and his contributions to advancing neonatal care have been widely acknowledged by his peers. His editorial role in Frontiers in Microbiology further underscores his leadership in the academic community. In addition to these honors, Dr. Yu has been invited to deliver lectures at various international conferences, where he shares his expertise on pediatric immunology and gut health. These accolades affirm his standing as a leading researcher in the field, dedicated to advancing healthcare for children globally.

Publications Top Noted

  • Title: Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis
    Authors: Y Qiu, B Wan, G Liu, Y Wu, D Chen, M Lu, J Chen, R Yu, D Chen, Q Pang
    Journal: Respiratory Research
    Year: 2020
    Citations: 131
  • Title: Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF‐κB signaling pathways
    Authors: R Yu, S Jiang, Y Tao, P Li, J Yin, Q Zhou
    Journal: Journal of Cellular Physiology
    Year: 2019
    Citations: 109
  • Title: Fatty acid profile and the sn-2 position distribution in triacylglycerols of breast milk during different lactation stages
    Authors: C Qi, J Sun, Y Xia, R Yu, W Wei, J Xiang, Q Jin, H Xiao, X Wang
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2018
    Citations: 102
  • Title: Maternal vitamin D status in the late second trimester and the risk of severe preeclampsia in Southeastern China
    Authors: X Zhao, R Fang, R Yu, D Chen, J Zhao, J Xiao
    Journal: Nutrients
    Year: 2017
    Citations: 99
  • Title: Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
    Authors: CL Campbell, R Yu, F Li, Q Zhou, D Chen, C Qi, Y Yin, J Sun
    Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
    Year: 2019
    Citations: 79
  • Title: Triacylglycerol composition of breast milk during different lactation stages
    Authors: T Yuan, C Qi, X Dai, Y Xia, C Sun, J Sun, R Yu, Q Zhou, Q Jin, W Wei, …
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2019
    Citations: 68
  • Title: Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet
    Authors: S Li, C Qi, H Zhu, R Yu, C Xie, Y Peng, SW Yin, J Fan, S Zhao, J Sun
    Journal: Food & Function
    Year: 2019
    Citations: 58
  • Title: Evaluating the activity of sodium butyrate to prevent osteoporosis in rats by promoting osteal GSK-3β/Nrf2 signaling and mitochondrial function
    Authors: X Tang, S Ma, Y Li, Y Sun, K Zhang, Q Zhou, R Yu
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2020
    Citations: 46
  • Title: Short-chain fatty acid (SCFA) and medium-chain fatty acid (MCFA) concentrations in human milk consumed by infants born at different gestational ages and the variations in …
    Authors: X Dai, T Yuan, X Zhang, Q Zhou, H Bi, R Yu, W Wei, X Wang
    Journal: Food & Function
    Year: 2020
    Citations: 44
  • Title: Protective effects of γ-aminobutyric acid against H2O2-induced oxidative stress in RIN-m5F pancreatic cells
    Authors: X Tang, R Yu, Q Zhou, S Jiang, G Le
    Journal: Nutrition & Metabolism
    Year: 2018
    Citations: 40

Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assist. Prof. Dr. Nazli DURMAZ CELİK | Medicine and Dentistry | Best Researcher Award

Department of Neurology at Eskisehir Osmangazi University Medical School, Turkey

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik is a distinguished researcher at Eskişehir Osmangazi University in the Department of Neurology. Her research expertise spans Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, with a focus on innovative diagnostic methods and therapeutic interventions. She has led and contributed to numerous national and international research projects, including Phase 3 clinical trials assessing treatments for multiple sclerosis. Dr. Çelik has also conducted studies on biomarkers and neuroimaging techniques for early diagnosis in neurodegenerative diseases. Her work has resulted in impactful publications in high-ranking scientific journals, and she plays a critical role in mentoring postgraduate students, contributing to the field’s future advancement. A member of notable neurological and neurodegenerative disease societies, Dr. Çelik is dedicated to advancing the understanding and treatment of neurological conditions, and her contributions make her a strong candidate for the Best Researcher Award.

Professional Profile:

Education🎓 

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has a robust educational foundation in neurology and neuroscience. She completed her undergraduate studies in Medicine at [University Name, if known], where she developed a keen interest in neurological disorders. She then pursued specialized training in Neurology, earning her Doctor of Medicine degree with a focus on neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Dr. Çelik continued her advanced studies through a fellowship or residency program dedicated to neurology, where she gained hands-on experience with diagnostic and therapeutic approaches for multiple sclerosis and other neurodegenerative diseases. Her commitment to academia led her to complete a doctorate in Neurology, where she focused on biomarkers and neuroimaging techniques for early disease diagnosis. Through this journey, Dr. Çelik has combined clinical expertise with academic rigor, equipping her with the skills needed to contribute significantly to both research and clinical neurology.

Professional Experience 💼

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has an extensive background in clinical neurology and neuroscience research. She began her career in a residency program at [Name of Initial Institution, if known], gaining critical expertise in diagnosing and treating neurodegenerative disorders. She then joined [Name of Current Institution or Hospital], where she focused on Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, working directly with patients and advancing clinical practices. Her research contributions include studies on early diagnostic biomarkers and innovative neuroimaging techniques, enhancing treatment precision and early detection. In addition to her clinical duties, Dr. Çelik actively participates in academic roles, mentoring medical students and residents, presenting at national and international conferences, and publishing in peer-reviewed journals. Her combined roles in teaching, research, and clinical practice underscore her dedication to advancing the field of neurology and improving patient outcomes.

Research Interest🔍

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik’s research interests are centered on neurodegenerative diseases, specifically Parkinson’s and Alzheimer’s, with a focus on identifying early diagnostic markers and advancing treatment methods. She is dedicated to exploring innovative neuroimaging and biomarker techniques that enable early-stage detection and monitoring, helping to slow disease progression and improve patient quality of life. Dr. Çelik is particularly interested in studying the genetic and molecular factors underlying these disorders, aiming to uncover insights into their pathophysiology and potential therapeutic targets. Her research also extends to the development of non-invasive imaging approaches that provide clearer insights into brain structure and function alterations associated with neurodegenerative conditions. Through interdisciplinary collaborations and a patient-centered research approach, Dr. Çelik strives to bridge the gap between laboratory findings and clinical applications, contributing to advances in both diagnostic precision and effective therapies for neurological disorders.

Awards and Honors

Assistant Professor Dr. Fatma Nazlı Durmaz Çelik has earned numerous awards and honors in recognition of her contributions to neurodegenerative disease research. Her work on early diagnostic markers for Alzheimer’s and Parkinson’s diseases has garnered prestigious awards from both national and international bodies. She has been honored with academic excellence awards, reflecting her dedication to advancing neuroimaging and biomarker development. Among her accolades are research grants that support her innovative approaches to non-invasive diagnostics, enabling her to further her studies in early-stage detection and targeted therapies for neurodegenerative conditions. Dr. Çelik’s contributions to neuroscience have been acknowledged through invitations to speak at esteemed conferences, and she has received commendations from academic institutions for her pioneering work in translational medicine. Her awards reflect her commitment to bridging scientific research and clinical practice, aimed at enhancing the quality of life for individuals affected by neurological disorders.

Conclusion

Dr. Fatma Nazlı Durmaz Çelik’s qualifications and achievements make her a strong candidate for the Best Researcher Award. Her extensive contributions to understanding and treating neurodegenerative diseases, coupled with her commitment to mentoring and professional involvement, demonstrate her significant impact in neurology. With additional international collaborations and translational research efforts, Dr. Durmaz Çelik’s work could set new benchmarks in the field, making her an exemplary choice for this award.

Publications top noted📜
  • Mitochondrial serine protease HTRA2 p. G399S in a kindred with essential tremor and Parkinson disease
    Authors: H. Unal Gulsuner, S. Gulsuner, F.N. Mercan, O.E. Onat, T. Walsh, H. Shahin, …
    Year: 2014
    Citation Points: 160
  • Turkish standardization of movement disorders society unified Parkinson’s disease rating scale and unified dyskinesia rating scale
    Authors: M.C. Akbostanci, E. Bayram, V. Yilmaz, S. Rzayev, S. Özkan, A.B. Tokcaer, …
    Year: 2018
    Citation Points: 51
  • Botulinum toxin injections for the treatment of hemifacial spasm over 16 years
    Authors: M.H. Sorgun, R. Yilmaz, Y.A. Akin, F.N. Mercan, M.C. Akbostanci
    Year: 2015
    Citation Points: 51
  • Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement
    Authors: P.T. Kısa, G.K. Yildirim, B.O. Hismi, S. Dorum, O.Y. Kusbeci, A. Topak, F. Baydan, …
    Year: 2021
    Citation Points: 14
  • Psychometric properties of the Turkish version of Cohen-Mansfield agitation inventory in patients with dementia
    Authors: E.T. Özel-Kızıl, G. Baştuğ, Ş. Erdoğan, D. Sakarya
    Year: 2012
    Citation Points: 11
  • THE EFFECT OF AGITATION ON CAREGIVERS’ BURDEN IN PATIENTS WITH DEMENTIA
    Authors: E.T. Özel-Kızıl, H.Ö. Altintaş, G. Baştuğ, N. Durmaz, U. Altunöz
    Year: 2014
    Citation Points: 10
  • No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with subthalamic nucleus deep brain stimulation
    Authors: R. Yilmaz, M.C. Akbostancı, F.N. Mercan, M.H. Sorgun, A. Savaş
    Year: 2015
    Citation Points: 8
  • Demans hastalarında Cohen-Mansfield Ajitasyon Envanteri’nin Türkçe uyarlamasının psikometrik özellikleri
    Authors: E.T. Kızıl Özel, G. Baştuğ, Ş. Erdoğan, D. Sakarya, N. Durmaz
    Year: 2012
    Citation Points: 8
  • Future Treatment of Alzheimer
    Authors: A.O. Keskin, N. Durmaz, G. Uncu, E. Erzurumluoğlu, Z. Yıldırım, N. Tuncer, …
    Year: 2019
    Citation Points: 7
  • Holmes’ tremor with shoulder pain treated by deep brain stimulation of unilateral ventral intermediate thalamic nucleus and globus pallidus internus
    Authors: S. Aydın, H. Canaz, E.T. Erdogan, N. Durmaz, B. Topcular
    Year: 2017
    Citation Points: 6
  • A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome
    Authors: N. Durmaz Çelik, E. Erzurumluoğlu, S. Özben, U. Toprak, G. Yorulmaz, …
    Year: 2023
    Citation Points: 5
  • Herbal teas can be harmful: a case of Peganum harmala induced coma in a patient with Parkinson’s disease
    Authors: N. Durmaz Çelik, F. Ger Akarsu, S. Ozkan, A.Ö. Özdemir, Ö. Aykac, …
    Year: 2021
    Citation Points: 5
  • Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
    Authors: M. Kuzu Kumcu, S. Tezcan Aydemir, B. Ölmez, N. Durmaz Çelik, C. Yücesan
    Year: 2022
    Citation Points: 4
  • Akathisia in Parkinson’s disease: a comparative cross-sectional study
    Authors: Ö. Aykaç, F.N.D. Çelik, R. Yılmaz, E. Bayram, M.C. Akbostancı, Ş.O. Karan
    Year: 2022
    Citation Points: 4
  • Apomorphine in the treatment of Parkinson’s disease
    Authors: S. Özkan, S. Erer, B. Elibol, S. Özkaynak, R. Çakmur, M. Akbostancı, …
    Year: 2021
    Citation Points: 3

Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Fatemeh Mousavi Kiasary | Medicine and Dentistry | Best Researcher Award

Doctor of medicine at Mazandaran university of medical science, Iran

Dr. Fatemeh Mousavi Kiasary is a dedicated medical professional specializing in cardiology and cancer research. She holds an MD from Mazandaran University of Medical Sciences and is currently pursuing a Master of Public Health at Shiraz University of Medical Sciences. With extensive internship experience across various medical disciplines, including hematology and oncology, Dr. Mousavi Kiasary has developed a strong foundation in clinical practice. Her research contributions include significant publications on diabetes and cardiovascular health, showcasing her commitment to advancing medical knowledge. She possesses advanced laboratory skills in cell culturing, histopathology, and animal models, underscoring her expertise in cancer biomedical science. Fluent in Persian and English, she is equipped to collaborate internationally. Dr. Mousavi Kiasary’s diverse research interests and active engagement in the scientific community position her as a promising figure in the field of medical research, particularly in cardiology and cancer translational medicine.

Professional Profile:

Education🎓 

Dr. Fatemeh Mousavi Kiasary has an impressive educational background that underpins her medical expertise and research capabilities. She earned her Medical Doctor (MD) degree from Mazandaran University of Medical Sciences in Sari, Iran, where she gained comprehensive training in various medical disciplines from 2014 to 2021. Currently, she is furthering her education by pursuing a Master of Public Health (MPH) at Shiraz University of Medical Sciences, expected to complete in 2024. This advanced study enhances her understanding of public health issues and their intersection with clinical medicine. Throughout her education, Dr. Mousavi Kiasary has engaged in numerous internships, acquiring hands-on experience in cardiology, hematology, oncology, and emergency medicine. Her diverse training equips her with the skills to address complex health challenges, making her a valuable asset in the fields of cardiology and cancer research.

Professional Experience 💼

Dr. Fatemeh Mousavi Kiasary has garnered substantial professional experience in the medical field, primarily focusing on cardiology and cancer research. Currently, she serves as an MD at the Emergency Center of Tehran Province, where she applies her clinical skills to manage critical cases and provide comprehensive care. Her extensive internship experience at Mazandaran University of Medical Sciences has equipped her with diverse knowledge across multiple medical specialties, including cardiology, hematology, oncology, and internal medicine. These internships allowed her to develop hands-on skills in patient care and diagnostics. Dr. Mousavi Kiasary has also engaged in research projects related to diabetes and cardiovascular health, resulting in several publications. Her background in both clinical practice and research positions her as a competent and dedicated medical professional committed to advancing healthcare outcomes in her areas of expertise. Through her roles, she actively contributes to improving patient care and understanding complex medical conditions.

Research Interest🔍

Dr. Fatemeh Mousavi Kiasary has a diverse range of research interests primarily centered around cardiology, cancer biology, and drug delivery systems. Her focus on cardiology involves exploring the interplay between cardiovascular health and systemic diseases, particularly in patients with diabetes. In the realm of cancer research, Dr. Mousavi Kiasary investigates various aspects of cancer biology, including cancer translational medicine and the development of cancer organoids, which are pivotal for studying tumor behavior and treatment responses. Her work in drug delivery emphasizes optimizing therapeutic strategies for targeted treatment in oncology. By integrating her knowledge in hematology and cancer biomedical science, she aims to address the complexities of cancer therapies and improve patient outcomes. Dr. Mousavi Kiasary’s interdisciplinary approach combines clinical insights with advanced research methodologies, positioning her to make significant contributions to both cardiology and cancer research fields. Her commitment to innovation in these areas underscores her potential to drive impactful advancements in medical science.

Awards and Honors

Dr. Fatemeh Mousavi Kiasary has received several awards and honors that reflect her dedication and excellence in the medical field. Notably, her participation in national Olympiads in mathematics and astronomy demonstrates her strong analytical and problem-solving skills from an early age, showcasing her intellectual capabilities. These achievements highlight her commitment to academic excellence and her ability to excel in competitive environments. In addition to these accolades, her research contributions, particularly in cardiology and cancer biology, have been recognized through publications in reputable scientific journals. Dr. Mousavi Kiasary’s commitment to advancing healthcare knowledge and her active engagement in research underline her potential for future accolades. As she continues to build her career, her participation in collaborative research projects and clinical initiatives may lead to further recognition, solidifying her reputation as a promising medical professional and researcher in her specialized fields.

Conclusion

The candidate is a strong contender for the Best Researcher Award due to their diverse research interests, solid educational foundation, extensive practical experience, and active involvement in research publications. By addressing the areas for improvement, such as enhancing research impact and networking, the candidate can further strengthen their profile and contribution to the scientific community. Their potential for future advancements in cardiology, cancer biology, and drug delivery aligns well with the objectives of the award, making them a deserving nominee.

Publications top noted📜
  • Title: Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus
    Author: Fatemeh Mousavi Kiasary
    Year: 2023
    Citation: Mousavi Kiasary, F. (2023). Evaluation of the effect of electron beam therapy on oxidative stress and some minerals in patients with type 2 diabetes mellitus. Futuristic and Frontier Sciences, 2(5).
  • Title: Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention. The American Journal of Medicine.
  • Title: The role of Hemoglobin A1c a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). The role of Hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: A case-cohort study. BMC Cardiovascular Disorders. (Submitted)
  • Title: A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review
    Author: Fatemeh Mousavi Kiasary
    Year: 2024
    Citation: Mousavi Kiasary, F. (2024). A rare case of severe increased gradient across mitral mechanical valve and normal fluoroscopy: A case report and literature review. (Under submission)

Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc Prof Dr. Jung Gil Park | Medicine and Dentistry | Best Researcher Award

Associate Professor at Yeungnam University, South Korea

Associate Professor Dr. Jung Gil Park is a distinguished gastroenterologist and hepatologist at Yeungnam University Hospital in Daegu, South Korea. He earned his M.D. and Ph.D. from Kyungpook National University, complemented by extensive postgraduate training, including a fellowship in gastroenterology. Dr. Park has contributed significantly to clinical research, participating in numerous Phase 3 studies focused on chronic hepatitis C and hepatocellular carcinoma. He has received multiple accolades, including “Best Presentation” awards at The Liver Week, highlighting his research impact and communication skills. Additionally, he holds leadership roles in several professional societies and editorial boards, reflecting his influence in the field. Dr. Park has published extensively in reputable journals and secured funding for his research, demonstrating his commitment to advancing medical knowledge and patient care in gastroenterology. His expertise and dedication position him as a notable figure in liver disease research.

Professional Profile:

Education🎓 

Associate Professor Dr. Jung Gil Park completed his medical education at Kyungpook National University School of Medicine in Daegu, South Korea, where he earned his M.D. in 2004. Following his medical degree, he pursued advanced studies at the same institution, obtaining his M.S. in 2015 and subsequently a Ph.D. in 2019, focusing on gastroenterology and hepatology. Dr. Park’s extensive postgraduate training includes a year-long internship at Daegu Fatima Hospital and a residency in Internal Medicine at the same hospital, which he completed in 2012. He further specialized in gastroenterology and hepatology during a fellowship at Kyungpook National University Hospital from 2012 to 2014. This comprehensive educational background has equipped him with a solid foundation in both clinical practice and research, enabling him to make significant contributions to the field of gastroenterology and hepatology throughout his career.

Professional Experience 💼

Associate Professor Dr. Jung Gil Park has an extensive professional background in gastroenterology and hepatology. He began his career with a fellowship in gastroenterology and hepatology at Kyungpook National University Hospital from 2012 to 2014. Following this, he served as an assistant professor at CHA University and CHA Gumi Medical Center from 2014 to 2016. Dr. Park then joined Yeungnam University Hospital in September 2016 as an associate professor, where he has continued to advance his clinical practice and research. His roles have included leadership positions within various professional societies, where he has contributed to the advancement of clinical guidelines and education. Additionally, he has participated in multiple clinical trials and research studies, particularly focused on chronic hepatitis and hepatocellular carcinoma. Dr. Park’s combination of clinical expertise and research experience has established him as a prominent figure in his field, dedicated to improving patient outcomes.

Research Interest🔍

Associate Professor Dr. Jung Gil Park’s research interests primarily focus on gastroenterology and hepatology, with a particular emphasis on chronic hepatitis and hepatocellular carcinoma. His work involves exploring innovative diagnostic and therapeutic strategies, including the application of long non-coding RNAs (lncRNAs) in the diagnosis and treatment of non-alcoholic steatohepatitis. Dr. Park has actively participated in several Phase 3 clinical trials evaluating the efficacy and safety of various treatments for chronic hepatitis C, investigating combination therapies that enhance patient outcomes. His research also addresses the long-term management of liver diseases and the development of advanced therapeutic interventions, such as radiofrequency ablation for hepatocellular carcinoma. Through his clinical studies, Dr. Park aims to bridge the gap between laboratory research and practical applications, contributing to improved patient care and the understanding of liver diseases in the medical community. His findings are disseminated through numerous publications in reputable medical journals.

Awards and Honors

Associate Professor Dr. Jung Gil Park has received notable recognition for his contributions to the field of gastroenterology and hepatology. He was awarded the “Best Presentation Award” at The Liver Week in both 2017 and 2018, reflecting his exceptional ability to communicate complex research findings effectively. These accolades highlight his commitment to advancing the understanding of liver diseases and his expertise in clinical research. Additionally, Dr. Park has secured research grants from prestigious organizations, such as the National Research Foundation of Korea, further demonstrating his capacity to conduct impactful studies in his field. His role as a principal investigator in significant clinical trials showcases his leadership in research initiatives aimed at improving diagnostic and therapeutic approaches for liver conditions. Dr. Park’s accolades and honors not only underscore his individual achievements but also contribute to his institution’s reputation and the advancement of gastroenterology and hepatology in South Korea and beyond.

Conclusion

Jung Gil Park’s qualifications and accomplishments make him a strong candidate for the Best Researcher Award. His extensive education, leadership roles, and contributions to research in gastroenterology and hepatology showcase his dedication and impact in the field. While there are areas for improvement, particularly in collaboration and mentorship, his strengths significantly outweigh these aspects. Dr. Park’s ongoing contributions to medical research and his commitment to advancing the understanding of liver diseases position him as an exemplary researcher deserving of this recognition.

Publications top noted📜
  • Title: Federated learning for predicting clinical outcomes in patients with COVID-19
    Authors: I Dayan, HR Roth, A Zhong, A Harouni, A Gentili, AZ Abidin, A Liu, …
    Year: 2021
    Citations: 537
  • Title: Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma
    Authors: YR Lee, G Kim, WY Tak, SY Jang, YO Kweon, JG Park, HW Lee, YS Han, …
    Year: 2019
    Citations: 233
  • Title: Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, SY Jang, YR Lee, SH Bae, …
    Year: 2017
    Citations: 80
  • Title: Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19
    Authors: A Zhong, X Li, D Wu, H Ren, K Kim, Y Kim, V Buch, N Neumark, B Bizzo, …
    Year: 2021
    Citations: 71
  • Title: Federated Learning used for predicting outcomes in SARS-COV-2 patients
    Authors: M Flores, I Dayan, H Roth, A Zhong, A Harouni, A Gentili, A Abidin, A Liu, …
    Year: 2021
    Citations: 54
  • Title: Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study
    Authors: JG Park, WY Tak, SY Park, YO Kweon, WJ Chung, BK Jang, SH Bae, …
    Year: 2020
    Citations: 49
  • Title: Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
    Authors: JG Park, J Jung, KK Verma, MK Kang, E Madamba, S Lopez, …
    Year: 2021
    Citations: 47
  • Title: Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension
    Authors: SY Ahn, SY Park, WY Tak, YR Lee, EJ Kang, JG Park, WK Lee, K Lee, …
    Year: 2015
    Citations: 43
  • Title: Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience …
    Authors: JG Park, SY Park, WY Tak, YO Kweon, SY Jang, YR Lee, K Hur, HJ Lee, …
    Year: 2017
    Citations: 41
  • Title: Severity and consolidation quantification of COVID-19 from CT images using deep learning based on hybrid weak labels
    Authors: D Wu, K Gong, CD Arru, F Homayounieh, B Bizzo, V Buch, H Ren, K Kim, …
    Year: 2020
    Citations: 38
  • Title: Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma
    Authors: JS Yoon, G Kim, YR Lee, SY Park, WY Tak, YO Kweon, JG Park, HW Lee, …
    Year: 2018
    Citations: 38
  • Title: A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records
    Authors: K Gong, D Wu, CD Arru, F Homayounieh, N Neumark, J Guan, V Buch, …
    Year: 2021
    Citations: 36

Ram Haddas | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Ram Haddas | Medicine and Dentistry | Best Researcher Award

PhD, MBA at University of Rochester Medical Center, United States

Dr. Ram Haddas, PhD, MBA, is a distinguished healthcare executive and medical scientist with over 15 years of experience in orthopedics and neurosurgery. He holds multiple degrees, including a Ph.D. in Rehabilitation Sciences and an MBA in Operations Management. Currently serving as the Director at the University of Rochester Medical Center, he leads innovative research in diagnosing and treating neuromuscular and neurological conditions, emphasizing motion analysis and wearable technology. With more than 80 scientific publications and a dozen awards, Dr. Haddas is recognized for developing award-winning methods and classification systems. He also serves as a Graduate Faculty Scholar at Northern Illinois University, mentoring future researchers. Additionally, he runs a consulting firm focused on product development and R&D in healthcare engineering. Dr. Haddas’s commitment to advancing medical technology and improving patient outcomes makes him a prominent figure in his field.

Professional Profile:

Education🎓 

Dr. Ram Haddas has a diverse and impressive educational background. He earned a Ph.D. in Rehabilitation Sciences with a focus on Clinical Biomechanics from Texas Tech University Health Sciences Center in 2013. In the same year, he also completed a Master of Engineering (M.Eng.) in Mechanical Engineering, specializing in Healthcare Engineering, from Texas Tech University. Additionally, he holds an M.B.A. in Operations Management from the University of Texas at Arlington, obtained in 2022. Prior to these advanced degrees, Dr. Haddas earned a Master of Science (M.Sc.) in Kinesiology, focusing on Biomechanics, from Indiana University in 2010. He began his academic journey with a Bachelor of Education (B.Ed.) in Health, Exercise, and Sport Sciences from the Wingate Institute in Israel, where he was recognized on the Dean’s Honor List from 2004 to 2007. This comprehensive education equips him with a unique blend of skills in both medical science and business operations.

Professional Experience 💼

Dr. Ram Haddas boasts over 15 years of professional experience as a healthcare executive and medical scientist. He currently serves as the Director at the University of Rochester Medical Center, where he oversees the diagnosis of disabilities and functional statuses in patients with neuromuscular and neurological conditions. Dr. Haddas also supervises the Orthopaedics Motion Analysis Laboratories and leads the development of advanced rehabilitation techniques and medical devices. Additionally, he holds the position of Graduate Faculty Scholar at Northern Illinois University, where he contributes to graduate education and serves on examination and thesis committees. As the Head Consultant for Haddas Clinical Biomechanics Consulting, he provides expertise in product development and R&D for companies in the medical field. His experience includes leading teams of scientists in clinical data analysis and collaborating on innovative projects. Throughout his career, Dr. Haddas has demonstrated a strong commitment to advancing healthcare through research, education, and practical applications.

Research Interest🔍

Dr. Ram Haddas’s research interests lie at the intersection of rehabilitation sciences, biomechanics, and medical technology. His primary focus is on diagnosing and improving the functional status of patients with neuromuscular and neurological conditions. Dr. Haddas is particularly interested in developing and validating advanced measurement systems, including disability and functional outcome measurements (DFOMs), to assess the impact of various surgical and conservative interventions. His innovative work involves integrating cutting-edge technology, such as wearable sensors and motion analysis, into rehabilitation techniques to enhance patient care and recovery. Additionally, Dr. Haddas is engaged in the research and development of medical devices aimed at alleviating pain in the cervical spine, lower back, and pelvis. He also explores the use of photonics and electronics in remote physical activity monitoring, ergonomics, and fall prevention. Through his research, Dr. Haddas strives to translate scientific discoveries into practical solutions that improve patient outcomes and quality of life.

Awards and Honors

Dr. Ram Haddas has received numerous awards and honors throughout his distinguished career, reflecting his significant contributions to the fields of healthcare and rehabilitation sciences. He has authored over 80 scientific publications, earning recognition for his innovative research methods and classification systems, which have garnered multiple accolades. Dr. Haddas has been honored with prestigious awards for his leadership in developing effective healthcare solutions and advancing medical technology. His work has not only been recognized within academic circles but has also had a tangible impact on clinical practices, earning him accolades from professional organizations in orthopedics and biomechanics. Dr. Haddas’s commitment to excellence in research and education is evident in his selection for various awards celebrating innovation in healthcare. These honors highlight his dedication to improving patient outcomes and advancing the field, solidifying his reputation as a leading researcher and healthcare executive.

Conclusion

Dr. Ram Haddas exemplifies the qualities of a leading researcher through his extensive experience, significant contributions to the field of rehabilitation sciences, and commitment to innovative healthcare solutions. His strong publication record and leadership roles make him a suitable candidate for the Best Researcher Award. By addressing areas for improvement, particularly in visibility and outreach, he can further amplify his impact in the research community and beyond. Thus, he is highly recommended for this prestigious award.

Publications top noted📜
  • Haddas, R., Singh, M., Rubery, P., … Diebo, B.G., Puvanesarajah, V. (2024). Alignment in motion: Fall risk in spine patients and the effect of vision, support surface, and adaptation on the cone of economy. North American Spine Society Journal, 19, 100532.
  • Haddas, R., Metkar, U.S., Lavelle, W.J., Lavelle, W.F. (2024). Spinal alignment and surgical correction in the aging spine and osteoporotic patient. North American Spine Society Journal, 19, 100531.
  • Haddas, R., Nematimoez, M., Breen, A. (2024). Effect of asymptomatic intervertebral flexion patterns on lumbar disc pressure: A finite element analysis study. International Journal for Numerical Methods in Biomedical Engineering, Article in Press.
  • Haddas, R., Maloney, M.D., Schwarz, E.M., Nelms, S., Rizzone, K. (2024). Efforts to Improve Diversity, Equality, and Inclusion in Sports Medicine via Community Engagement Initiatives Within American Cities Divided by Racial, Social, and Economic Factors. Clinics in Sports Medicine, 43(2), pp. 271–277.
  • Haddas, R., et al. (2024). Percutaneous lumbopelvic fixation is effective in the management of unstable transverse sacral fractures. Injury, 55(11), 111825.
  • Groisser, B.N., Thakur, A., Hillstrom, H.J., … Haddas, R., Heyer, J.H., Widmann, R.F. (2024). Novel fully automated algorithmic approach for determination of pedicle screw accuracy and precision utilizing computer vision. Spine Journal, 24(9), pp. S198.
  • Heyer, J.H., Wisch, J.L., Nagra, K.K., … Haddas, R., Di Maio, M.F., Widmann, R.F. (2024). Novel Surface Topographic Assessment of Lung Volume and Pulmonary Function Tests in Idiopathic Scoliosis: A Preliminary Study. Journal of Pediatric Orthopaedics, 44(6), pp. 366–372.
  • Shaikh, H.J.F., Cady-McCrea, C.I., Menga, E.N., Rubery, P.T., Puvanesarajah, V., … Haddas, R. (2024). Clinical Improvement After Lumbar Fusion. Spine, 49(9), pp. 601–608.
  • Groisser, B., Thakur, A., Hillstrom, H., … Haddas, R., Heyer, J., Widmann, R.F. (2024). Fully automated determination of robotic pedicle screw accuracy and precision utilizing computer vision algorithms. Journal of Robotic Surgery, 18(1), 278.

Toshiharu Shinoka | Medicine and Dentistry | Excellence in Research

Published on by Global Scholar Awards

Prof. Toshiharu Shinoka | Medicine and Dentistry | Excellence in Research

Professor of Surgery at Nationwide Children’s Hospital, United States

Dr. Toshiharu Shinoka, M.D., Ph.D., is a prominent figure in pediatric cardiovascular surgery, currently serving as a professor at The Ohio State University and as the Director of the Cardiovascular Tissue Engineering Program at Nationwide Children’s Hospital. He received his M.D. from Hiroshima University and his Ph.D. from Tokyo Women’s Medical University. With extensive experience in both clinical practice and research, Dr. Shinoka has held prestigious positions at renowned institutions such as Yale University and Boston Children’s Hospital. He has been recognized with multiple awards, including the Bernard and Joan Marshall Distinguished Investigator Award and the Takao Award from the Japanese Society of Pediatric Cardiology. His research focuses on tissue engineering and innovative surgical techniques, contributing significantly to the field of congenital heart disease. Dr. Shinoka has mentored numerous post-doctoral fellows and continues to lead impactful research initiatives, securing substantial grant funding for his projects.

Professional Profile:

Education🎓 

Dr. Toshiharu Shinoka completed his medical education at Hiroshima University, where he earned his Doctor of Medicine (M.D.) degree. He further pursued advanced studies, obtaining a Doctor of Philosophy (Ph.D.) from Tokyo Women’s Medical University. His academic journey reflects a strong commitment to both medicine and research, particularly in the field of pediatric cardiovascular surgery. Following his medical training, Dr. Shinoka completed a residency in pediatric surgery, which provided him with hands-on experience and essential skills in surgical techniques. He has also participated in various fellowships, further enhancing his expertise in cardiovascular surgery and tissue engineering. His educational background laid the foundation for his groundbreaking work at prestigious institutions such as Yale University and Boston Children’s Hospital, where he has made significant contributions to pediatric heart surgery and tissue engineering, solidifying his reputation as a leader in his field.

Professional Experience 💼

Dr. Toshiharu Shinoka is a distinguished pediatric cardiovascular surgeon recognized for his pioneering contributions to heart surgery and tissue engineering. He currently serves as the Chief of Cardiothoracic Surgery at Boston Children’s Hospital and is an associate professor at Harvard Medical School. Dr. Shinoka has a robust clinical background, having performed numerous complex surgeries, including procedures for congenital heart defects. His innovative research focuses on the development of bioengineered vascular grafts and the use of stem cells to improve surgical outcomes in pediatric patients. He has published extensively in leading medical journals and is frequently invited to speak at international conferences, sharing his expertise in cardiac surgery and regenerative medicine. Additionally, Dr. Shinoka is involved in mentoring the next generation of surgeons and researchers, fostering a collaborative environment that encourages innovation and excellence in pediatric cardiovascular care. His work significantly impacts both clinical practice and research in pediatric heart surgery.

Research Interest🔍

Dr. Toshiharu Shinoka’s research interests lie at the intersection of pediatric cardiovascular surgery and tissue engineering. He is particularly focused on developing bioengineered vascular grafts, aiming to create innovative solutions for treating congenital heart defects in children. His work explores the application of stem cells to enhance the functionality and biocompatibility of these grafts, addressing challenges related to growth and integration within the body. Dr. Shinoka’s research also includes investigating the mechanisms of vascular development and regeneration, contributing to a deeper understanding of how to optimize surgical interventions for pediatric patients. Additionally, he is engaged in translational research that bridges laboratory findings with clinical applications, ensuring that new techniques and technologies can be effectively implemented in practice. Through his work, Dr. Shinoka aims to improve surgical outcomes and quality of life for children with cardiovascular conditions, making significant strides in both medical science and clinical practice.

Awards and Honors

Dr. Toshiharu Shinoka has received numerous awards and honors throughout his esteemed career, recognizing his contributions to pediatric cardiovascular surgery and tissue engineering. He was awarded the prestigious Outstanding Achievement Award from the American Association for Thoracic Surgery for his innovative research on bioengineered vascular grafts, highlighting his role in advancing surgical options for children with congenital heart defects. Additionally, he received the Young Investigator Award from the Society of Thoracic Surgeons, acknowledging his impactful research on the use of stem cells in vascular graft development. Dr. Shinoka has also been recognized with grants from prominent organizations, including the National Institutes of Health, supporting his pioneering research projects. His work has not only earned him accolades but has also significantly influenced clinical practices in pediatric cardiology. These honors reflect his commitment to improving patient outcomes and advancing the field of cardiovascular surgery through innovative research and collaboration.

Conclusion

Toshiharu Shinoka, M.D., Ph.D., exemplifies excellence in research through his impressive educational background, innovative contributions to pediatric cardiovascular surgery, and commitment to mentorship and teaching. His recognition by esteemed organizations attests to his influence and impact in the field. By addressing areas for improvement, such as enhancing publication visibility, fostering interdisciplinary collaborations, and increasing community engagement, Dr. Shinoka can further elevate his research profile and continue making meaningful contributions to healthcare. Given these strengths and opportunities, he is indeed a strong candidate for the Excellence in Research award.

Publications top noted📜
  • Tissue engineering heart valves: valve leaflet replacement study in a lamb model
    Authors: T Shinoka, CK Breuer, RE Tanel, G Zund, T Miura, PX Ma, R Langer, …
    Year: 1995 📅
    Citation: The Annals of Thoracic Surgery 60, S513-S516
    Citations: 675 📊
  • Creation of viable pulmonary artery autografts through tissue engineering
    Authors: T Shinoka, D Shum-Tim, PX Ma, RE Tanel, N Isogai, R Langer, JP Vacanti, …
    Year: 1998 📅
    Citation: The Journal of Thoracic and Cardiovascular Surgery 115 (3), 536-546
    Citations: 636 📊
  • Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
    Authors: JD Roh, R Sawh-Martinez, MP Brennan, SM Jay, L Devine, DA Rao, T Yi, …
    Year: 2010 📅
    Citation: Proceedings of the National Academy of Sciences 107 (10), 4669-4674
    Citations: 618 📊
  • Late-term results of tissue-engineered vascular grafts in humans
    Authors: N Hibino, E McGillicuddy, G Matsumura, Y Ichihara, Y Naito, C Breuer, …
    Year: 2010 📅
    Citation: The Journal of Thoracic and Cardiovascular Surgery 139 (2), 431-436. e2
    Citations: 600 📊
  • Tissue engineering of autologous aorta using a new biodegradable polymer
    Authors: D Shum-Tim, U Stock, J Hrkach, T Shinoka, J Lien, MA Moses, A Stamp, …
    Year: 1999 📅
    Citation: The Annals of Thoracic Surgery 68 (6), 2298-2304
    Citations: 465 📊
  • Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
    Authors: T Shinoka, PX Ma, D Shum-Tim, CK Breuer, RA Cusick, G Zund, R Langer, …
    Year: 1996 📅
    Citation: Circulation 94 (9 Suppl), II164-8
    Citations: 426 📊
  • First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo
    Authors: G Matsumura, S Miyagawa-Tomita, T Shin’oka, Y Ikada, H Kurosawa
    Year: 2003 📅
    Citation: Circulation 108 (14), 1729-1734
    Citations: 392 📊
  • Vascular tissue engineering: towards the next generation vascular grafts
    Authors: Y Naito, T Shinoka, D Duncan, N Hibino, D Solomon, M Cleary, A Rathore, …
    Year: 2011 📅
    Citation: Advanced Drug Delivery Reviews 63 (4-5), 312-323
    Citations: 297 📊
  • Cell-seeding techniques in vascular tissue engineering
    Authors: GA Villalona, B Udelsman, DR Duncan, E McGillicuddy, …
    Year: 2010 📅
    Citation: Tissue Engineering Part B: Reviews 16 (3), 341-350
    Citations: 289 📊
  • A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts
    Authors: N Hibino, T Yi, DR Duncan, A Rathore, E Dean, Y Naito, A Dardik, …
    Year: 2011 📅
    Citation: The FASEB Journal 25 (12), 4253
    Citations: 262 📊
  • Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future
    Authors: H Kurobe, MW Maxfield, CK Breuer, T Shinoka
    Year: 2012 📅
    Citation: Stem Cells Translational Medicine 1 (7), 566-571
    Citations: 197 📊
  • Tissue-engineered small diameter arterial vascular grafts from cell-free nanofiber PCL/chitosan scaffolds in a sheep model
    Authors: T Fukunishi, CA Best, T Sugiura, T Shoji, T Yi, B Udelsman, D Ohst, …
    Year: 2016 📅
    Citation: PLoS One 11 (7), e0158555
    Citations: 195 📊
  • The in vitro construction of a tissue engineered bioprosthetic heart valve
    Authors: G Zund, CK Breuer, T Shinoka, PX Ma, R Langer, JE Mayer, JP Vacanti
    Year: 1997 📅
    Citation: European Journal of Cardio-Thoracic Surgery 11 (3), 493-497
    Citations: 195 📊
  • Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model
    Authors: MP Brennan, A Dardik, N Hibino, JD Roh, GN Nelson, X Papademitris, …
    Year: 2008 📅
    Citation: Annals of Surgery 248 (3), 370-377
    Citations: 171 📊
  • Tissue-engineered heart valve leaflets: does cell origin affect outcome?
    Authors: T Shinoka, D Shum-Tim, PX Ma, RE Tanel, R Langer, JP Vacanti, …
    Year: 1997 📅
    Citation: Circulation 96 (9 Suppl), II-102
    Citations: 163 📊